Trial Profile
Study of retapamulin against methicillin-resistant staphylococcus aureus infection pediatric patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Dec 2019
Price :
$35
*
At a glance
- Drugs Retapamulin (Primary) ; Retapamulin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 13 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018